The carnitine transporter SLC22A5 Is not a general drug transporter, but It efficiently translocates mildronate

Drug Metabolism and Disposition

Volumn 37, Issue 2, 2009, Pages 330-337

  Grigat, Silke ^a   Fork, Christian ^a   Bach, Markus ^a   Golz, Stefan ^b   Geerts, Andreas ^b   Schömig, Edgar ^a   Gründemann, Dirk ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; CEFALORIDINE; GABAPENTIN; MEPYRAMINE; MESSENGER RNA; METHYL IODIDE; MILDRONATE; ORGANIC ANION TRANSPORTER 2; QUINIDINE; SPIRONOLACTONE; TETRYLAMMONIUM; THIONEINE; VERAPAMIL; VIGABATRIN;

ANIMAL TISSUE; ARTICLE; CHEMICAL STRUCTURE; CHICKEN; CONTROLLED STUDY; DRUG TARGETING; DRUG TRANSPORT; DRUG UPTAKE; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; TISSUE DISTRIBUTION;

ANIMALS; BIOLOGICAL TRANSPORT; CARNITINE; CHICKENS; CLONING, ORGANISM; FEMALE; HUMANS; MEMBRANE TRANSPORT PROTEINS; METHYLHYDRAZINES; ORGANIC CATION TRANSPORT PROTEINS; POLYMERASE CHAIN REACTION; RATS;

RATTUS;

EID: 59649127836     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.023929     Document Type: Article

References (28)

1. Bach M, Grigat S, Pawlik B, Fork C, Utermöhlen O, Pal S, Banczyk D, Lazar A, Schömig E, and Gründemann D (2007) Fast set-up of doxycycline-inducible protein expression in human cell lines with a single plasmid based on Epstein-Barr virus replication and the simple tetracycline repressor. FEBS J 274:783-790.
2. Dambrova M, Liepinsh E, and Kalvinsh I (2002) Mildronate: cardioprotective action through carnitine-lowering effect. Trends Cardiovasc Med 12:275-279.
3. Ganapathy ME, Huang W, Rajan DP, Carter AL, Sugawara M, Iseki K, Leibach FH, and Ganapathy V (2000) beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter. J Biol Chem 275:1699-1707.
4. Georges B, Le Borgne F, Galland S, Isoir M, Ecosse D, Grand-Jean F, and Demarquoy J (2000) Carnitine transport into muscular cells. Inhibition of transport and cell growth by mildronate. Biochem Pharmacol 59:1357-1363.
5. Grigat S, Harlfinger S, Pal S, Striebinger R, Golz S, Geerts A, Lazar A, Schömig E, and Grundemann D (2007) Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations. Biochem Pharmacol 74:309-316.
6. Grube M, Meyer zu Schwabedissen HE, Präger D, Haney J, Möritz KU, Meissner K, Rosskopf D, Eckel L, Bohm M,̈ Jedlitschky G, et al. (2006) Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation 113:1114-1122.
7. Gründemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N, Rubbert A, and Schömig E (2005) Discovery of the ergothioneine transporter. Proc Natl Acad Sci U SA 10:5256-5261.
8. Grundemann D, Liebich G, Kiefer N, Köster S, and Schömig E (1999) Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 56:1-10.
9. Harlfinger S, Fork C, Lazar A, Schomig E, and Grundemann D (2005) Are organic cation transporters capable of transporting prostaglandins? Naunyn Schmiedebergs Arch Pharmacol 372:125-130.
10. Hilgendorf C, Ahlin G, Seithel A, Artursson P, Ungell AL, and Karlsson J (2007) Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab Dispos 35:1333-1340.
11. Horvath G, Schmid N, Fragoso MA, Schmid A, Conner GE, Salathe M, and Wanner A (2007) Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway. Am J Respir Cell Mol Biol 36:53-60.
12. Kuwajima M, Harashima H, Hayashi M, Ise S, Sei M, Lu K, Kiwada H, Sugiyama Y, and Shima K (1999) Pharmacokinetic analysis of the cardioprotective effect of 3-(2,2, 2-trimethylhy- drazinium) propionate in mice: inhibition of carnitine transport in kidney. J Pharmacol Exp Ther 289:93-102.
13. Liepinsh E, Vilskersts R, Loca D, Kirjanova O, Pugovichs O, Kalvinsh I, and Dambrova M (2006) Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma- butyrobetaine contents and cardioprotection in isolated rat heart infarction. J Cardiovasc Pharmacol 48:314-319.
14. Lu K, Nishimori H, Nakamura Y, Shima K, and Kuwajima M (1998) A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis mouse. Biochem Biophys Res Commun 252:590-594.
15. Martel F, Martins MJ, and Azevedo I (1996) Inward transport of 3H-MPP+ in freshly isolated rat hepatocytes: evidence for interaction with catecholamines. Naunyn Schmiedebergs Arch Pharmacol 354:305-311.
16. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, et al. (1999) Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:91-94.
17. Ohashi R, Tamai I, Nezu Ji J, Nikaido H, Hashimoto N, Oku A, Sai Y, Shimane M, and Tsuji A (2001) Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol Pharmacol 59:358-366.
18. Ohashi R, Tamai I, Yabuuchi H, Nezu JI, Oku A, Sai Y, Shimane M, and Tsuji A (1999) Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 291:778 -784.
19. Schömig E, Babin-Ebell J, and Russ H (1993) 1,1′-Diethyl-2, 2′-cyanine (decynium22) potently inhibits the renal transport of organic cations. Naunyn Schmiedebergs Arch Pharmacol 347:379-383.
20. Schömig E, Babin-Ebell J, Russ H, and Trendelenburg U (1992) The force driving the extran- euronal transport mechanism for catecholamines (uptake2). Naunyn Schmiedebergs Arch Pharmacol 345:437-443.
21. Schomig E, Lazar A, and Gründemann D (2006) Extraneuronal monoamine transporter and organic cation transporters 1 and 2-a review of transport efficiency, in Handbook of Experimental Pharmacology-Neurotransmitter Transporters (Sitte HH and Freissmuth M eds) pp 151-180, Springer, Heidelberg, Germany.
22. Sekine T, Kusuhara H, Utsunomiya-Tate N, Tsuda M, Sugiyama Y, Kanai Y, and Endou H (1998) Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine. Biochem Biophys Res Commun 251:586-591.
23. Sjakste N, Gutcaits A, and Kalvinsh I (2005) Mildronate: an antiischemic drug for neurological indications. CNS Drug Rev 11:151-168.
24. Stein WD (1986) Transport and Diffusion Across Cell Membranes, Academic Press, Orlando.
25. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, and Tsuji A (1998) Molecular and functional identification of sodium ion-dependent, high affinity human carni-tine transporter OCTN2. J Biol Chem 273:20378-20382.
26. Urban TJ, Brown C, Castro RA, Shah N, Mercer R, Huang Y, Brett CM, Burchard EG, and Giacomini KM (2008) Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin. Clin Pharmacol Ther 83:416-421.
27. Wagner CA, Lükewille U, Kaltenbach S, Moschen I, Broer A, Risler T, Broer S, and Lang F (2000) Functional and pharmacological characterization of human Na+-carnitine cotransporter hOCTN2. Am J Physiol 279:F584-F591.
28. Wu X, Prasad PD, Leibach FH, and Ganapathy V (1998) cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246:589-595.